Clovis Oncology Inc (NASDAQ:CLVS)

1.68
Delayed Data
As of Jun 24
 -0.06 / -3.45%
Today’s Change
0.58
Today|||52-Week Range
6.65
-38.01%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +78.57% increase from the last price of 1.68.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Hold stock in Clovis Oncology Inc. This rating has held steady since May, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.41
Sales
$37.0M
Reporting Date
Aug 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.06%
 
 
 
 
 
 
Growthannually 27.37%
 
 
 
 
 
 

Sales

Growthquarterly 8.12%
 
 
 
 
 
 
Growthannually 4.07%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.